Recent Advances in Immune-Based Therapies for Type 1 Diabetes | Zendy

Darja Šmigoc Schweiger | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Recent Advances in Immune-Based Therapies for Type 1 Diabetes

Author(s) -

Darja Šmigoc Schweiger

Publication year - 2022

Publication title -

hormone research in paediatrics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.816

H-Index - 89

eISSN - 1663-2826

pISSN - 1663-2818

DOI - 10.1159/000524866

Subject(s) - medicine , disease , immune system , immunotherapy , immunology , autoimmunity , diabetes mellitus , clinical trial , t cell , type 2 diabetes , pathogenesis , bioinformatics , endocrinology , biology

Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by progressive destruction of the pancreatic beta cells, leading to a lifelong dependence on insulin. It is associated with an increased morbidity and mortality from diabetes-related complications and a significant treatment burden. However, there has been substantial progress in therapeutic strategies that can affect the course of the disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research